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Abstract
Background—Empirically derived and tested models are necessary to develop effective, holistic 
interventions to improve positive health outcomes in adolescents and young adults (AYA) with 
cancer, yet few exist. This paper is the second of two papers reporting on evaluation of the 
Resilience in Illness Model (RIM) as a predictive model to guide positive health research and 
practice.
Objective—To report the confirmatory model evaluation of the RIM.
Methods—A confirmatory evaluation of RIM was done using baseline data from a sample of 113 
AYA aged 11 to 24 years who were undergoing hematopoietic stem cell transplant and enrolled in 
a randomized controlled trial of a behavioral intervention to enhance resilience. Data were 
analyzed using latent variable structural equation modeling.
Results—Goodness-of-fit indices supported RIM as a confirmed model and accounted for large 
amounts of variance in the outcomes of self-transcendence (62%) and resilience (72%), and in 
three of five mediators, specifically social integration (74%), courageous coping (80%), and hope-
derived meaning (87%) as well as small to moderate amounts of variance in the remaining 
mediators of defensive coping (1%) and family environment (35%).
Conclusions—Findings establish the RIM as a plausible predictive framework for explaining 
ways AYA with cancer transcend their illness and achieve resilience resolution, and for guiding 
intervention studies in this population. Additional research is needed to explore RIM's 
transferability based on stage of illness, other chronic diseases, and cultural diversity.
Implications for Practice—Results support the RIM as an appropriate guide for developing 
and evaluating interventions to foster positive adjustment in AYA with cancer.
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Adolescents and young adults (AYA) with cancer have markedly poorer outcomes 
throughout their cancer journey, compared to children and older adults. 1 The well 
documented challenges these AYA face include, but are not limited to, symptom distress, 
uncertainty, infertility, fear of recurrence, spiritual and existential distress, social isolation, 
problems with family communication and relationships, disruptions to developmental tasks 
(e.g. intimacy and independence), and traumatic stress symptoms. 2-7 Information and 
support services to address AYA concerns and challenges are lacking, and there are few well 
designed and tested interventions. 2, 3, 8 Between 1988 and 2015, only 12 controlled 
intervention studies targeting AYA were reported, and of these only 7 were guided by an 
explicit theoretical framework. 9, 10
In addition to the unmet needs of AYA with cancer, there are few empirically derived and 
tested models to guide research for this population. 11 Such models are necessary to develop 
effective, holistic interventions aimed at improving AYA positive health outcomes. To 
explain how positive health is fostered in AYA, the Resilience in Illness Model (RIM) was 
developed through a series of qualitative and quantitative studies, using data from AYA with 
cancer and other chronic conditions. 12-15 This paper is the second of two papers reporting 
on evaluation of the RIM as a predictive model to guide research and practice. 13
In the first paper (Part 1), we described evaluation of the exploratory RIM, hereafter referred 
to as E-RIM. 13 To increase confidence in the ability of RIM to predict and guide 
intervention and outcomes research, it is important to evaluate how well the model is 
replicated in a different sample. This paper reports evaluation of the confirmatory RIM, 
hereafter referred to as C-RIM, using a sample of 113 AYA with cancer and recruited at the 
consenting stage of hematopoietic stem cell transplant (HSCT) to participate in a 
randomized clinical trial of a therapeutic music video intervention. 16 The data obtained for 
use in this study was funded by the National Institute of Nursing Research (R01NR008583) 
and the National Cancer Institute as a Children's Oncology Group study ANUR0631 
(R01NR008583; U10CA180886; UG1CA189955; U10CA098543; U10CA095861).
The Resilience in Illness Model
A detailed description of RIM development, exploratory evaluation, and listing of latent 
variables with definitions of RIM concepts are described in Part 1. Briefly, RIM was 
developed from a positive health perspective to gain understanding of factors that contribute 
to AYA positive adjustment to chronic illness. The final best-fitting E-RIM consisted of two 
risk factors, illness-related distress (uncertainty and symptom distress) and defensive coping 
(avoidant, fatalistic, and emotive coping); five protective factors including spiritual 
perspective (one's self-defined spiritual beliefs and practices), social integration (perceived 
support from friends and healthcare providers), family environment (adaptability, cohesion, 
perceived strengths), hope-derived meaning, and courageous coping (optimistic, confrontive, 
and supportant coping); and two outcome factors self-transcendence, measured as activities 
and perspectives individuals engage in to expand their boundaries; and resilience (the 
process of identifying or developing resources and strengths to flexibly manage stressors to 
gain a sense of confidence/mastery, self-transcendence, and self-esteem). The E-RIM 
accounted for large amounts of variance for the two outcome variables (63% for self-
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transcendence, 67% for resilience resolution) and one mediating variable (76% for hope-
derived meaning) and small to moderate amounts of variance (18 – 52 %) for the mediating 
variables of defensive coping, family environment, and social integration.
DESIGN AND METHODS
For the C-RIM, the study design was a cross-sectional theory evaluation, using baseline data 
obtained prior to AYA assignment to experimental or low dose control intervention 
conditions in our randomized controlled trial. 16 Hypotheses for the C-RIM were based on 
the final E-RIM. 13 We hypothesized two outcomes, resilience and self-transcendence, and 
regarding these outcomes, we hypothesized: (a) self-transcendence will be directly 
influenced by courageous coping, illness-related distress and spiritual perspective, and 
indirectly influenced by defensive coping, family environment, and social integration; and, 
(b) resilience resolution will be directly influenced by courageous coping and hope-derived 
meaning, and indirectly influenced by defensive coping family environment, social 
integration, illness-related distress, and spiritual perspective.
Setting and Sample
The parent study was conducted at eight sites that included 9 pediatric hospitals affiliated 
with the Children's Oncology Group and 3 adult hospitals affiliated with 3 of the pediatric 
hospitals. Participant inclusion criteria were: (a) AYA aged 11 through 24 years; (b) 
diagnosed with cancer and consented to receive an allogeneic or autologous stem cell 
transplant that required a myeloablative regimen; and (c) able to read and speak English. 
Exclusion criteria were: (a) having a cancer that does not usually occur in AYA populations; 
(b) cognitive impairments making it difficult to complete data collection instruments; and, 
(c) being married and/or having children. Figure 1 describes participant recruitment and 
accrual outcomes. Reasons for declining participation were consistent with published 
literature on AYA recruitment to RCT studies. 17 Demographic information for the sample is 
presented in Table 1. The participants, aged 11 to 24 years (M=17.3, SD=3.8), were 
primarily male (58%) with 83% Non-Hispanic and 58.4% Caucasian. The most common 
primary cancer diagnosis was leukemia (46.4%) and grouping disease status into high and 
low risk categories, 55% had were high risk.
Measures
The same 20 measures used for the E-RIM evaluation listed in Table 2 were used for the C-
RIM. These measures and their psychometric properties are fully described in the E-RIM 
manuscript, Part 1, Table 3.13 Internal consistency reliabilities (Cronbach's α) for the C-RIM 
measures are reported in Table 2. Cronbach's α coefficients were in an acceptable range (.75 
to .94) for all measures with the exception of 3 sub-scales that each had a small number of 
items (i.e., 4 -5 items). As expected, Cronbach's α coefficients for these subscales were 
lower (.60 to .65). Construct validity of the measures in the context of AYA with cancer 
enrolled in this study is supported based on hypothesized intercorrelations (Table 3) and the 
final confirmatory measurement model (Figure 2).
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Procedures
Institutional Review Board approval for the parent study was obtained at each site prior to 
approaching potential participants. Baseline data were obtained following informed written 
consent from AYA > 17 years or assent from AYA < 18 years with parental consent. The 
timeframe for baseline data collection ranged from 30 days prior to AYA admission to 1 
week after admission. This timeframe encompasses the pre-transplant phase, when AYA 
physical symptom distress is usually less severe. Data were collected in a quiet, in-hospital 
or clinic setting by Certified Research Associates or healthcare professionals with a graduate 
degree. All evaluators completed a two-day training seminar on study-specific data 
collection procedures prior to collecting data. Participants entered their responses directly 
into a secure web-based data collection site developed specifically for this study. 18 During 
data collection sessions, an evaluator was present the entire time to answer questions and 
assist with technology issues. Time to complete baseline data collection ranged from 60-90 
minutes. Several strategies (e.g. evaluator training and masking, audio-recording of sessions; 
secure computer data entry done by the AYA) were used to insure evaluation integrity 
procedures. 19
Data Analyses
We used MPLUS software to perform C-RIM confirmatory factor analysis (CFA) and 
structural equation modeling (SEM). In addition, we used the robust version of maximum 
likelihood estimation, in which estimated standard errors and statistical tests are robust to 
violations of normality assumptions. 20 Criteria for goodness of fit were evaluated using the 
comparative fit index (CFI) between .92 and .99, standardized root mean square residual 
(SRMR) < .08, and root mean square error of approximation (RMSEA) between .06 to .
09. 21 Modifications to the models were explored using the MPLUS indices for adding 
paths, and p-values for dropping paths to achieve the best-fitting model. 20
RESULTS
Confirmatory measurement model
Initial analysis of CFA revealed that the data fit the C-RIM reasonably well (Figure 2; CFI = 
0.92, SRMR = .06, and RMSEA = .07). The 90% confidence interval for the RMSEA fit 
statistic (.06, .09) indicated that the estimation precision of the model was very good, despite 
a significant chi-square of 222.73 with 136 degrees of freedom and p < .0001. Using 
MPLUS indices and theory to guide decision making, 14, 15 eleven modified versions of the 
measurement model were investigated (e.g., two subscales of the uncertainty in illness scale 
were used as indicators of illness-related distress; instead of a combined score, emotive and 
evasive coping subscales were used as separate indicators of defensive coping; fatalistic 
coping was added as an indicator of defensive coping; and, religious activity was added as a 
third indicator of spiritual perspective).
Confirmatory structural model
The C-RIM factor analysis (CFA) presented in Figure 2 was used as the basis for testing the 
C-RIM structural equation model (SEM) in Figure 3. The data fit the C-RIM SEM 
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reasonably well (CFI = 0.92, SRMR = .07, and RMSEA = .07 with a 90% CI = .05, .09). 
Consistent with the E-RIM, the full C-RIM accounted for high levels of variance: 72% of 
resilience resolution and 62% of self-transcendence. Based on these confirmed findings, to 
distinguish resilience as process from resilience as outcome, the latent outcome variable 
previously labeled “resilience” was changed to “resilience resolution.” In the C-RIM, 
variance of the proximal outcomes accounted for large to moderate amounts of courageous 
coping (80%), hope-derived meaning (87%), and social integration (74%) and small to 
moderate amounts of family environment (35%) and defensive coping (1%).
DISCUSSION
Findings indicated that the hypothesized C-RIM measurement model and full model fit 
reasonably well with baseline data of AYA undergoing stem cell transplant. Consistent with 
the E-RIM, the C-RIM accounted for high levels of variance in the distal outcomes of 
resilience resolution and self-transcendence and proximal outcomes of courageous coping, 
hope-derived meaning and social integration. Path differences between the E-RIM and C-
RIM were anticipated due to substantive differences in the samples, including time since 
diagnosis and position in the cancer trajectory (i.e., newly diagnosed, relapsed, beginning 
stem cell transplant regimen, survivorship, end-of-life). The E-RIM included a 
heterogeneous sample of AYA across the cancer trajectory, on and off treatment, and with 
good and poor prognoses. In contrast, the C-RIM sample included only AYA beginning the 
process of receiving a stem cell transplant regimen. Comparison of the E-RIM and C-RIM 
suggests that various time points and illness circumstances influences illness-related distress, 
emotional availability of family and friends, coping, and hope-derived meaning. Regardless 
of the differences in paths across models, especially considering differences between the 
samples across studies, findings establish the RIM as a predictive framework that accounts 
for ways AYA with cancer transcend their illness and achieve resilience. The C-RIM study 
results support the RIM as an appropriate guide for developing and evaluating interventions 
to foster positive adjustment in AYA with cancer.
Resilience Redefined
Based on the E-RIM and C-RIM findings, and to distinguish resilience as process from 
resilience as outcome, we revised the definition of resilience presented in Part 1 as follows.
• In the context of illness resilience as a process is defined as the degree to which 
individuals identify, develop, and/or engage protective resources (i.e., spiritual 
perspective, social integration, family environment, courageous coping, and 
hope-derived meaning) to flexibly manage illness-related stressors (i.e., illness-
related distress and defensive coping) in order to achieve the two-fold outcomes, 
resilience resolution and self-transcendence.
• In the context of illness, resilience resolution is defined as the degree to which 
individuals: (a) gain a sense of mastery, accomplishment and competency related 
to managing the illness situation; (b) are motivated to continue to maintain and 
improve the situation and help and inspire others; and, (c) acknowledge and 
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accept that the illness experience contributes to, but does not predominately 
define oneself as a person.
This revised definition of resilience resolution closely aligns with the illness resolution 
described in Haase's qualitative research on courage in chronically ill adolescents, which 
was the basis of the Resilience in Illness measure developed to support the RIM. 14
Juxtaposition of Illness-related Distress and Spiritual Perspective as Key Influences
The juxtaposition of illness-related distress (i.e., symptom distress and illness uncertainty) 
and spiritual perspective (i.e., spiritual beliefs and practices) in relation to other protective 
and risk factors is highly compelling. Specifically, the RIM paths indicate when illness-
related distress is high and/or not well-managed, the potential for AYA to successfully 
transcend the illness experience is likely to be significantly diminished, and the protective 
factors of courageous coping and social integration are likely to be less effective. 
Conversely, the paths indicate that when AYA have a strong spiritual perspective, resilience 
resolution and ability to transcend the illness are likely to be enhanced, even in the midst of 
illness-related distress; and, family environment, hope-derived meaning, and courageous 
coping are likely to be enhanced as protective factors.
Management of Illness-Related Distress—The significant direct negative paths 
between illness-related distress (uncertainty and symptom distress) and courageous coping, 
social integration, and self-transcendence underscore the importance of attending to 
symptoms and uncertainty as a top priority of care providers. The RIM indicates AYA will 
have difficulty self-transcending when illness-related distress is high and/or not well-
managed. This finding is supported by other research showing strong relationships between 
symptom distress, uncertainty, and traumatic stress symptoms in AYA with cancer. 22-26
Uncertainty management—Although uncertainty management interventions are 
promising in adult populations, there remains a great need for interventions tailored to the 
unique developmental needs of AYA. 22, 27 Several intervention approaches are possible. 
First, the level of uncertainty of newly diagnosed AYA could be assessed, and then 
addressed and monitored as their cancer and treatment status change. To manage the 
uncertainty, AYA require information specific to their cancer trajectory, provided in amounts 
and at times that are appropriate to their age and coping skills, and in formats that are 
appealing and accessible. 27 Perhaps the most obvious and important intervention strategy to 
decrease uncertainty is increased skillful communication by healthcare providers that is 
timely, developmentally appropriate, and empathically delivered regarding diagnosis, 
prognosis, and what to expect during their treatment course. 24 Because cancer-related 
information is often complex, ambiguous, and emotionally difficult, providing written 
information and/or directing AYA to age-relevant information sources, such as web-sites, 
may be a helpful component of an uncertainty intervention. To take in, understand, make 
decisions about, and act on information relevant to their cancer journey, interventions 
designed to support effective expression and communication of their thoughts and emotions 
are needed. There is evidence that uncertainty in AYA and families also may be alleviated 
through social support and the expression of feelings in ways that are comfortable for AYA, 
such as through music and therapies.28-31 Lastly, research with childhood cancer survivors 
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indicates that, although uncertainty can be a source of distress, when it is well attended to, it 
can also be a catalyst for growth, greater awareness of life purpose, development of 
confidence, resilience, and optimism. 28
Symptom Management—It is often difficult to assess and manage symptoms in AYA. 
Toxicities experienced by AYA are often more severe than those experienced by children 
receiving identical treatment regimens. 32 Additional research is needed to understand the 
differences in pharmacological responses for AYA, develop ways to assess AYA symptoms 
and symptom clusters, and most importantly, develop AYA specific symptom management 
strategies. 33, 34 Because it is often difficult to assess symptom distress in AYA, innovative 
strategies to obtain symptom distress information from AYA are needed, and palliative care 
experts should be consulted early for assessment and management of symptoms.
Spiritual Perspective—The RIM indicates spiritual perspective a strong protective factor 
for AYA, their family and friends, and it may serve as a counterbalance to illness-related 
distress. Despite the potential beneficial influence of spiritual perspective on outcomes, there 
is a paucity of research on spirituality in general and specifically for AYA. 35-37 This 
significant influence of spiritual perspective is supported by the National Consensus Project 
Guidelines and National Quality Preferred Practices for Spiritual Domain Guidelines 
encouraging provision of spiritual care as a fundamental component of compassionate, 
patient-centered, and developmentally appropriate care; 36 however, additional research is 
needed on ways to appropriately implement the guidelines for AYA. Additional AYA-
specific research needs include: 1) evaluation and, if necessary, adaptation of existing 
theories of spirituality for their relevance to AYA, or development of AYA specific theories; 
2) use of mixed methods approaches to provide a holistic perspective of spirituality in AYA; 
3) research on AYA spiritual perspectives in the context of illness (e.g., how spiritual 
perspectives influence or are influenced by the illness experience); 4) interventions that help 
AYA express their spiritual perspectives in the context of illness; and, 5) development of 
measures of spiritual perspective that are based on AYA perceptions. 35
Social Integration and Family Environment
In the C-RIM, both social integration (i.e., the support AYA receive from friends and 
healthcare providers) and family environment (i.e., the ways families perceive their family, 
communicate, adapt, and are cohesive) serve as protective factors that foster hope-derived 
meaning and courageous coping. The influence of AYA's social network, including family, 
friends and connected healthcare providers is well supported in the literature; 7, 38 however, 
based on the C-RIM, the influence of these two factors on courageous coping, hope-derived 
meaning, and resilience may be mitigated when illness-related distress is high, such as 
during HSCT. In addition, for AYA to benefit from these protective factors, they may require 
assistance to maintain social relationships, inform others about their condition, deal with 
feeling different, and keep up with school activities. 39 A predominant theme in qualitative 
studies of AYA is the nature of the provider/patient relationship and the importance of 
connectedness. 14, 40, 41 In general, adults often struggle to effectively communicate with 
AYA and there are few effective interventions available that help adults learn ways to open 
and sustain communication with AYA about what is important to them—what their hopes, 
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values, beliefs, and concerns are, especially related to the cancer. 10 To enact their protective 
roles, additional intervention research is needed on ways to help families, friends, and 
healthcare providers effectively care for themselves so they remain emotionally available to 
the AYA. Recently, there is increased attention on helping healthcare providers learn 
effective ways to communication that expresses emotional support for AYA, 42, 43 which has 
been linked to better treatment compliance and reduced depression and anxiety in AYA with 
cancer. 44
Interactions of Defensive and Courageous Coping
Defensive ways of coping (i.e., avoidant, emotive, and fatalistic) are most often used when a 
situation, such as a diagnosis of cancer or high symptom distress, is appraised as a threat. 
Based on stress/coping literature, defensive ways of coping are usually sustained until 
adequate time and resources are available to address the source of threat and/or to develop 
context-specific courageous coping skills to manage the threat.45 Examples of context-
specific courageous coping skills for cancer are: learning more about the cancer; reframing 
the cancer experience from an insider perspective; adapting previous or learning new coping 
strategies to deal with cancer-related concerns, treatments, and procedures; and, learning 
comfortable ways to share cancer-related experiences with healthcare providers, family or 
friends. 40, 46 The RIM supports coping literature that indicates without development of 
courageous ways of coping over time, defensive ways of coping may become problematic, 
leading to risk-taking behaviors, withdrawal, and depression. 47, 48 The RIM also indicates 
prolonged defensive coping may be a barrier to transcendence or resilience resolution, 
ultimately affecting quality of life.
Hope-derived Meaning as a Pathway to Resilience Resolution
The C-RIM indicates hope-derived meaning is influenced by spiritual perspective, social 
integration and family environment. These three protective factors may be promising 
intervention targets to foster resilience resolution through hope-derived meaning. Research 
to understand the ways to foster hope-derived meaning directly and through these protective 
factors is needed. The Self-Sustaining Process Model provides a useful framework for 
fostering hope through self-reflection on several hope-fostering and sustaining thought 
processes that are congruent with the RIM (e.g. Spiritual--“God will take care of me”; Social 
Integration and Family Environment-“Others have hope for me”; Optimistic Courageous 
Coping-Knowledge of survivors).49, 50 Because AYA may have difficulty verbally 
communicating their experiences of coping, creative arts therapies, such music therapy 
interventions, offer promising alternative, effective ways to help AYA learn new and positive 
ways to cope with the cancer experience. 16
Study Limitations
Two study limitations identified for the E-RIM also apply to the C-RIM, specifically: 1) self-
report scales that raise questions of distortion of recall, lack of objectivity, and social 
desirability; and, 2) cross sectional data. These limitations should be weighed in light of the 
importance of self-report measures as a way to describe experiences. Concerns regarding 
social desirability were likely negligible, given that in this study: measures had normal 
distribution patterns; there were very little missing data; and qualitative interview data from 
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parents and AYA participating indicate the measures were not burdensome. A third 
limitation, unique to this study, was our use of a homogenous sample of AYA being admitted 
for HSCT. Although the homogeneity of our study sample can be viewed as a limitation, it 
also allowed us to examine pathways in the RIM that may vary across the cancer treatment 
trajectory and with treatment severity.
Research and Clinical Implications
Here we describe implications of the RIM for assessment and management of risk and 
protective factors. Addressing illness-related distress is crucial throughout the cancer 
continuum, from diagnosis through survivorship or end-of-life; however, when AYA are on 
active treatment--receiving chemotherapy, radiation, and/or HSCT, even the most skilled 
clinicians struggle to manage the symptom distress and uncertainty of their patients and 
families. According to the RIM, enhancing protective factors can potentially offset illness-
related distress and help AYA self-transcend and attain resilience resolution.
Research Implications—Researchers should consider using the RIM to identify gaps in 
knowledge and to develop interventions to address both risk and protective factors in the 
RIM relevant to AYA. Research is needed on ways protective factors can best be assessed 
and fostered to help AYA self-transcend the cancer experience and achieve resilience 
resolution. Future research on the model should systematically assess RIM factors 
longitudinally over time, beginning at diagnosis and at key times in the cancer trajectory, 
such as following cancer response evaluations and relapse. In addition, researchers are 
encouraged to consider the Children's Oncology Group (COG) Nursing Discipline 
Committee's adapted RIM to guide research with a broader population of pediatric cancer 
patients and families.51
Clinical Implications—Clinicians are encouraged to identify best practices for each 
protective factor. Following are just a few suggestions for clinical actions targeting RIM 
protective factors that could be incorporated into an AYA plan of care.
(a) Spiritual Perspective. Enhance spiritual care by routinely and systematically 
assessing and addressing spiritual distress (e.g., despair/hopelessness, need for 
reconciliation, anger at God) and meeting spiritual needs (e.g., ask about 
spiritual beliefs and practices and supporting their use). 35, 36
(b) Hope-derived Meaning. Foster realistic hope by providing clear and accurate 
information about the cancer prognosis and treatment options and by 
encouraging reflection on experiences among AYA, family, and friends, focusing 
on what is meaningful and important to them in the midst having cancer.
(c) Social Integration. Acknowledge the difficulty of missing out with friends and 
facilitate AYA efforts to stay connected with friends and other cancer survivors 
as sources of support.39 Foster connectedness by encouraging healthcare 
providers to use strategies that foster a sense of connectedness, such as being 
watchful and attentive to the AYA's unique needs; displaying a willingness to 
foster a relationship; using humor; and communicating in a way that conveys 
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respect, and assuring respectful care that supports AYA autonomy to the fullest 
extent possible.
(d) Assess and address family distress, so parents can be emotionally available to 
their AYA. Help parents learn active listening skills to communicate with their 
AYA through active listening.
(e) Evaluate the repertoire of coping skills AYAs have and use, assisting them to 
evaluate the effectiveness of any defensive coping strategies while working to 
enhance positive coping skills. Specifically, assist AYA to: acquire needed 
information about their cancer and treatments; gain an optimistic perspective 
(e.g., through upward and downward comparisons of AYA who are doing well 
and not doing well); and feel comfortable asking for support from others.
In closing, the RIM has promising research and clinical implications for reducing risk and 
enhancing positive health and well-being. While it is beyond the scope of this paper to 
comprehensively discuss all the potential ways the RIM may be used to guide research and 
practice, the RIM does provide a “big picture” view of ways to address both risk and 
protective factors. Researchers may find the RIM a useful guide for designing interventions 
and to identify meaningful measures and outcomes to target. The RIM may also facilitate 
clinicians’ efforts to systematically adopt a holistic approach to care for AYA with cancer.
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Figure 1. 
Recruitment
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Figure 2. 
Measurement model
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Figure 3. 
Confirmed structural equation modeling
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Table 1
Baseline Demographics
Demographics n Mean/%
Age (mean (SD); range) 113 17.3 (3.8); 11-24
Gender (%) 113
    Female 42.5
    Male 57.5
Hispanic (%) 113
    No 83.2
    Yes 16.8
Race (%) 113
    African-American 10.6
    White 58.4
    More than one race 20.4
    Othera 6.2
    Unknown or not reported 4.4
Currently attend school (%) 111
    No 32.4
    Yes 67.6
Level of school completed (%) 111
    Grade school 31.5
    High school 44.1
    College 24.3
Household income (%) 113
    <$25,000 18.6
    $25,000-$75,000 41.6
    >$75,000 27.4
    Unknown or not reported 12.4
Religious activity participation (%) 112
    Inactive or infrequent 51.8
    Occasional or regular 48.2
Employment status (%) 112
    Full-time 7.1
    Part-time 12.5
    Not employed 80.4
Primary diagnosis (%) 112
    Leukemia 46.4
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Demographics n Mean/%
    Lymphoma 25.0
    Solid tumor 28.6
Transplant type (%) 112
    Autologous 40.2
    Allogeneic/Syngeneic 59.8
Disease status at transplant (%) 111
    Low risk 54.1
    High risk 45.9
a
Includes American Indian, Alaskan Native, Asian, Native Hawaiian, Pacific Islander and other race.
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